BiomX Inc. (PHGE) Earnings Call Transcripts

22 earnings calls from August 2021 to June 26, 2026

NYSEAM US Health Care Biotechnology

BiomX Inc.'s Latest Earnings Call - April 10, 2026

During the special meeting held on April 10, 2026, BiomX Inc. approved the 2026 Equity Incentive Plan, which includes the issuance of up to 1,390,000 shares of common stock. The approval of this plan is significant as it introduces an evergreen mechanism for share issuance, potentially impacting future equity dilution. However, no financial metrics such as revenue or earnings were discussed in this meeting, and no guidance was provided for the upcoming fiscal year.

Reported metrics

MetricValueContext
Shares Approved for Issuance 1,390,000 (positive) Approval of the 2026 Equity Incentive Plan
Annual Increase Percentage 4% (positive) Evergreen mechanism for share issuance
Total Shares Outstanding 6,543,516 (neutral) As of April 10, 2026
Shares Present at Meeting 3,401,604 (positive) Quorum achieved for the meeting

Guidance from management

No financial guidance or forecasts were provided during the meeting. The focus was primarily on the approval of the equity incentive plan.

What management said

All having voted who wish to do so, the polls are declared to be closed. Based upon a preliminary count, we have sufficient votes to approve the 2026 plan. On the basis of such report, I hereby declare that the 2026 plan is approved. This completes the business of our agenda. If you have any additional questions for any member of the management, questions may be submitted to the web page. We will respond to appro...
— Michael Oster, April 10, 2026 earnings call

What analysts pressed on

Analysts may be concerned about the potential dilution from the approved equity incentive plan and how it will affect existing shareholders. There was no discussion on financial performance metrics or future earnings guidance, which could raise questions about the company's growth trajectory.

Main topics on the call

Read the full BiomX Inc. transcript (April 10, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About BiomX Inc.

BiomX Inc. (PHGE) is a publicly listed company in the Biotechnology industry, within the Health Care sector. It trades on NYSEAM and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 22 calls on record spanning August 16, 2021 to June 26, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 22 BiomX Inc. earnings call transcripts on record, spanning August 16, 2021 to June 26, 2026. Based on this history, BiomX Inc. reports quarterly. The most recent call on file is dated June 26, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
PHGE
Exchange
NYSEAM
Country
US
Sector
Health Care
Industry
Biotechnology
Calls on record
22
First call
August 16, 2021
Most recent
June 26, 2026
Reporting cadence
quarterly
Quarter Date
Shareholder/Analyst Calls Jun 26, 2026 Read transcript
Shareholder/Analyst Calls Apr 10, 2026 Read transcript
Q3 FY2025 Nov 12, 2025 Read transcript
Q2 FY2025 Aug 13, 2025 Read transcript
Special Calls Apr 3, 2025 Read transcript
Special Calls Mar 31, 2025 Read transcript
Q3 FY2024 Nov 14, 2024 Read transcript
Q2 FY2024 Aug 15, 2024 Read transcript
Q1 FY2024 May 21, 2024 Read transcript
Q4 FY2023 Apr 3, 2024 Read transcript
Special Calls Nov 29, 2023 Read transcript
Q2 FY2023 Aug 9, 2023 Read transcript
Q1 FY2023 May 15, 2023 Read transcript
Q4 FY2022 Mar 29, 2023 Read transcript
Special Calls Feb 22, 2023 Read transcript
Q3 FY2022 Nov 9, 2022 Read transcript
Q2 FY2022 Aug 10, 2022 Read transcript
Special Calls May 12, 2022 Read transcript
Q1 FY2022 May 11, 2022 Read transcript
Q4 FY2021 Mar 30, 2022 Read transcript
Q3 FY2021 Nov 15, 2021 Read transcript
Q2 FY2021 Aug 16, 2021 Read transcript